Roland Collicott
Roland Collicott is the senior consultant and founder of Chalpharm consultancy. Roland has a broad background in pharmaceutical R&D. He is widely experienced in analytical method development and validation and other CMC issues to regulatory requirements.
Having worked in a range of pharmaceutical companies: Glaxo, British Biotech and OSI Pharmaceuticals, Roland has demonstrated an adaptability and flexibility. He has achieved a number of successes in his career:
- Compiled documentation for CMC sections of regulatory dossiers.
- Managed stability studies, established shelf lives and provided this information to the regulatory agencies as required.
- Outsourced analytical work to external contractors and maintained good relationships with collaborators in a number of countries.
- Specialised in strategies for chiral analysis.
- Established preferred methods for characterisation of polymorphs, improving the quality and turn-round time of polymorph analysis.
- Built dedicated teams to deliver high quality validated methods for the analysis of development compounds. Sustained loyalty of teams while undergoing company restructuring.
- Engendered excellent relationships within project teams to ensure effective collaboration.
- Set up lab and procedures to handle high potency compounds, allowing the company to work with cytotoxic compounds for cancer treatment.
Employment
OSI Pharmaceuticals (UK) Ltd
Section Head, managing the development and validation of analytical methods.
Responsible for stability testing of drug substance and drug products, and
establishment of shelf lives. Represented the company on UK pharmaceutical
sciences group (PASG). Collation of data from a variety of sources for polymorphism
studies. Coordination of analysis using a wide range of techniques, from internal
and external facilities. Worked effectively with contractors, principally
in Europe and US.
British Biotech, Oxford, UK
Managed a team of graduates, providing analytical support for development
and manufacturing chemistry. Development and validation of analytical methods
to ICH guidelines. Specialised in chiral and polymorphic analysis.
Glaxo Group Research, Greenford, UK
Comprehensive foundation in analytical chemistry, culminating as senior scientist.
Specialised in chromatography. Introduced HPLC as a chiral separation tool.
Used preparative chromatography to isolate unknown impurities for analysis
by MS and NMR.
Qualifications and registrations
PhD (Synthesis of novel organosilicon compounds for the chiral analysis of pharmaceutical compounds).
Grad RSC.
Member of:
- Royal Society of Chemistry
- Pharmaceutical Analytical Sciences Group
- RSC/Royal Pharmaceutical Society of Great Britain Joint Pharmaceutical Analysis Group
- Chromatographic Society.